Sven Francque, Department of Gastroenterology and Hepatology, University of Antwerp, Belgium, presents Phase 2 data showing that lanifibranor induces MASH resolution and fibrosis regression, and looks forward to upcoming Phase 3 trial results.
Please login or create a FREE account to view this content
Educational Supporters of the 12th Closed Scientific Expert Meeting of the Editorial Board
Principal supporters:





Guest supporters:

